Health
Third Dose of mRNA COVID-19 Vaccine in Patients With RA With an Inadequate Response to Previous Doses – Rheumatology Advisor
Authors of a report published in Lancet Rheumatology reported on the safety and tolerability of a third mRNA COVID-19 vaccine…
In the majority of patients with rheumatoid arthritis (RA) who had an inadequate response to the antispike protein 1 (S1) with the previous 2 doses of the COVID-19 vaccine, a homologous third vaccine dose and temporary discontinuation of disease-modifying…
Continue Reading
-
Noosa News19 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
General12 hours agoAustralia Kangaroos lose Xavier Coates and Zac Lomax ahead of rugby league Ashes in England
-
Business21 hours agoDroneShield announces new $13 million counter-drone facility as employees top 400
-
Business22 hours agoWhy you should sell CBA, Lynas, and Tabcorp shares today